Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

BSMINational standardBiocompatibilityMedical devicesMedium confidenceLast verified October 4, 2026

CNS 14393-1

Biological evaluation of medical devices - Part 1: Evaluation and testing (Taiwan national standard, 2004 edition)

Current edition

2004

About this standard

Taiwan national standard, part 1 of the CNS 14393 series on biological evaluation of medical devices. The series follows the parts of ISO 10993. The TFDA recognized list also names the ISO 10993-1 edition of 2018.

The text of this standard is sold by BSMI and is not reproduced here. This page gives the code, edition, scope and what each market says about it.

Recognition by market

Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts

  • TaiwanNational equivalent
    Edition accepted
    2004
    National code
    CNS 14393-1
    Biological evaluation of medical devices - Part 1: Evaluation and testing

    Listed in the TFDA list of recognized standards. TFDA describes such standards as voluntary references, not mandatory rules.. The older national series is still on the 2026 list next to the ISO 10993 editions.

Related standards: ISO 10993-1, MFDS biological safety common standard, GB/T 16886.1-2022, GB/T 16886.4-2022, GB/T 16886.5-2017, GB/T 16886.7-2015, GB/T 16886.10-2017, GB/T 16886.11-2021, GB/T 16886.12-2017, GB/T 16886.18-2022, ISO 10993-9, ISO 10993-15. See all standards.

Not legal or regulatory advice. Check the current official rules before you act. Parts of the approvals data are official open data reused under open licences. Data sources.

LinkedInLinkedInXXYouTubeYouTube